Control of osteoclast differentiation

Critical Reviews in Eukaryotic Gene Expression

Volumn 8, Issue 1, 1998, Pages 1-17

  Reddy, Sakamuri V ^a   Roodman, G David ^a,b  

^a Univ of Texas Health Science Center ^*  (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Bone resorption; Cytokines; Differentiation; Hormones; Osteoclast; Stromal cells; Transcription factors

Indexed keywords

CADMIUM; CALCITONIN; CALCITRIOL; CALCIUM; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 4; INTERLEUKIN 6; IPRIFLAVONE; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PROSTAGLANDIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; ZINC;

ANIMAL CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; MACROPHAGE ACTIVATION; MEMBRANE BINDING; NONHUMAN; ONCOGENE C FOS; ONCOGENE SRC; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; STROMA CELL;

ANIMALIA;

EID: 0032470492     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v8.i1.10     Document Type: Review

References (114)

1. Abe J, Takita Y, Nakano T, Miyaura C, Suda T, Nishii Y (1989): A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124:2645-2647.
2. Abu-Amer Y, Ross FP, Schlesinger P, Tondravi MM, Teitelbaum SL (1997): Substrate recognition by osteoclast precursors induces c-src/microtubule association. J Cell Biol 137:247-258.
3. Agarwala N, Gay CV (1992): Specific binding of parathyroid hormone to living osteoclasts. J Bone Miner Res 7(5):531-539.
4. Anderson BM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L (1997): A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390(6656):175-179.
5. Biskobing DM, Fan D, Rubin J (1997): Induction of carbonic anhydrase II expression in osteoclast progenitors requires physical contact with stromal cells. Endocrinology 138:4852-4857.
6. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GR (1989): Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125(3):1142-1150.
7. Boyce BF, YonedaT, Lowe C, Soriano P, Mundy GR (1992): Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90(4):1622-1627.
8. Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble (1993): Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci USA 90:5578-5582.
9. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD (1988): Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683-5687.
10. 2 inhibits formation of osteoclast-like cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor-β. J Bone Miner Res 5:677-681.
11. 3 on osteoclast-like cell formation in normal human bone marrow culture. J Bone Miner Res 13:393-399.
12. Fan X, Biskobing DM, Fan D, Hofstetter W, Rubin J (1997): Macrophage colony stimulating factor downregulates M-CSF receptor expression and entity of progenitors into the osteoclast lineage. J Bone Miner Res 12:1387-1395.
13. Felix R, Cecchini MC, Fleisch H (1990): Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592-2594.
14. Feyen JH, Elford P, Di Padova FE, Trechsel U (1989): Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res 4:633-638.
15. Franchi-Miller C, Saffar JL (1995): The 5-lipoxygenase inhibitor BWA4C impairs osteoclastic resorption in a synchronized model of bone remodeling. Bone 17:185-191.
16. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA (1996): Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Annals of Rheum Dis 55:816-822.
17. Gallwitz WE, Mundy GR, Lee CH, Qiao M, Roodman GD, Raftery M, Gaskell SJ, Bonewald LF (1993): 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem 268(14): 10087-10094.
18. Galvin RJ, Bryan P, Horn JW, Rippy MK, Thomas JE (1996): Development and characterization of a porcine model to study osteoclast differentiation and activity. Bone 19:271-279.
19. Garcia C, Boyce BF, Gilles J, Dallas M, Qiao M, Mundy GR, Bonewald LF (1996): Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 11:1619-1627.
20. Girasole G, Passeri G, Jilka RL, Manolagas SC (1994): Interleukin 11: a new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524.
21. Gorn AH, Rudolph SM, Flannery MR, Morton CC, Weremowicz S, Wang TZ, Krane SM, Goldring SR (1995): Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction. J Clin Invest 95:2680-2691.
22. Gowen M, Mundy GR (1986): Actions of recombinant interleukin-1, interleukin-2, and interferon gamma on bone resorption in vitro. J Immunol 136:2478-2482.
23. Greenfield EM, Horowitz MC, Lavish SA (1996): Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J Biol Chem 271:10984-10989.
24. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF (1994): c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448.
25. Hakeda Y, Hiura K, Sato T, Olazaki R, Matsumoto T, Ogata E, Ishitani R, Kumegawa M (1989): Existence of parathyroid hormone binding sites on murine hemopoietic blast cells. Biochem Biophys Res Comm 163:1481-1486.
26. Halasy J, Hofstetter W (1998): Expression of colony-stimulating factor-1 (CSF-1) during the formation of osteoclasts in vivo. Bone 22:27S (abstract).
27. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM (1996): Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122:3151-3162.
28. Hill PA, Reynolds JJ, Meikle MC (1995): Osteoblasts mediate insulin-like growth factor-I and -II stimulated osteoclast formation and function. Endocrinology 136:124-131.
29. Holloway WR, Collier FM, Herbst RE, Hodge JM, Nicholson GC (1996): Osteoblast-mediated effects of zinc on isolated rat osteoclasts: Inhibition of bone resorption and enhancement of osteoclast number. Bone 19:137-142.
30. Holt I, Davie MW, Braidman IP, Marshall MJ (1994): Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones. Calcif Tiss Intl 52:114-119.
31. Horton MA, Lewis D, McNulty K, Pringle JAS, Chambers TJ (1985): Monoclonal antibodies to osteoclastomas (giant cell bone tumors): Definition of osteoclast-specific cellular antigens. Cancer Res 45:5663-5669.
32. Hoyland J, Sharpe PT (1994): Upregulation of c-fos protooncogene expression in pagetic osteoclasts. J Bone Miner Res 9(8):1191-1194.
33. Ikegame M, Rakopoulos M, Zhou H, Houssami S, Martin TJ, Moseley JM, Findlay DM (1995): Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res 10:59-65.
34. Inoue D, Santiago P, Horne WC, Baron R (1997): Identification of an osteoclast transcription factor that binds to the human T cell leukemia virus type I-long terminal repeat enhancer element. J Biol Chem 272:25386-25393.
35. Kania JR, Kehat-Stadler T, Kupfer SR (1997): CD44 antibodies inhibit osteoclast formation. J Bone Miner Res 12:1155-1164.
36. Kartsogiannis V, Udagawa N, Ng KW, Martin TJ, Moseley JM, Zhou H (1998): Localization of parathyroid hormone-related protein in osteoclasts by in situ hybridization and immunohistochemistry. Bone 22:189-194.
37. Khalkhali-Ellis Z, Collin-Osdoby P, Li L, Brandi ML, Osdoby P (1997): A human homolog of the 150 kDa avian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29.1 cells. Calcif Tiss Intl 60:187-193.
38. Kishi S, Yamaguchi M (1994): The inhibitory effects of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 48:1225-1230.
39. Kishi S, Yamaguchi M (1997): Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse bone marrow cultures: Interactions with dexamethasone. Molec Cell Biochem 166:145-151.
40. Kukita A, Kukita T, Shin JH, Kohashi O (1993): Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells. Biochem Biophys Res Commun 196:1389-1389.
41. Kukita T, Roodman GD (1989): Development of a monoclonal antibody to osteoclasts formed in vitro which recognizes mononuclear osteoclast precursors in the marrow. Endocrinology 125:630-637.
42. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD (1990): IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 144:4226-4230.
43. Kurihara N, Chenu C, Civin CI, Roodman GD (1990a): Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures. Endocrinology 126:2733-2741.
44. Kurihara N, Roodman GD (1990b): Interferons-α and -γ inhibit interleukin-1β-stimulated osteoclast-like cell formation in long-term human marrow cultures. J Interferon Res 10(5):541-547.
45. Kurihara N, Civin C, Roodman GD (1991): Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 6:257-261.
46. Lee SK, Goldring SR, Lorenzo JA (1995): Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136:4572-4581.
47. Lewis DB, Liggitt HD, Effmann EL, Motley ST, Teitelbaum SL, Jepsen KJ, Goldstein SA, Bonadia J, Carpenter J, Perlmutter RM (1993): Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 90:11618-11622.
48. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P (1993): Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 90(10):4485-4489.
49. Mbalaviele G, Orcel P, Morieux C, Njweide PJ, de Vernejoul MC (1995): Osteoclast formation from human cord blood mononuclear cells co-cultured with mice embryonic metatarsals in the presence of M-CSF. Bone 16:171-177.
50. McSheehy PMJ, Chambers TJ (1986): Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824-828.
51. 3 receptor. J Bone Miner Res 12:S330 (Abstract).
52. Miyauchi A, Notoya K, Taketomi S, Takagi Y, Fujii Y, Jinnai K, Takahashi K, Chihara K, Fujita T (1996): Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function. Endocrinology 137:3544-3550.
53. Moonga BS, Dempster DW (1995): Zinc is a potent inhibitor of osteoclastic bone resorption in vitro. J Bone Miner Res 10:453-457.
54. Musashi M, Yang YC, Paul SR, Clark SC, Sudo T, Ogawa M (1991): Direct and synergistic effects of interleukin-11 on murine hemopoiesis in culture. Proc Natl Acad Sci USA 88:765-769.
55. Nakano Y, Watanabe K, Morimoto I, Okada Y, Ura K, Sato K, Kasono K, Nakamura T, Eto S (1994): Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. J Bone Miner Res 9(10):1533-1539.
56. Nilsson SK, Lieschke GJ, Garcia-Wijnen CC, Williams B, Tzelepis D, Hodgson G, Grail D, Dunn AR, Bertoncello I (1995): Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 86(1):66-72.
57. Notoya K, Yoshida K, Taketomi S, Yamazaki I, Kumegawa M (1993): Inhibitory effect of ipriflavone on osteoclast mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells. Calc Tiss Intl 53:206-209.
58. Ohsaki Y, Takahashi S, Scarcez T, Demulder A, Nishihara T, Williams R, Roodman GD (1992): Evidence for an autocrine/paracrine role for IL-6 in bone resorption by giant cell tumors of bone. Endocrinology 131:2229-2234.
59. Orlandini SZ, Formigli L, Benvenuti S, Lasagni L, Franchi A, Masi L, Bernabei PA, Santini V, Brandi ML (1995): Functional and structural interactions between osteoblastic and preosteoclastic cells in vitro. Cell & Tissue Res 281:33-42.
60. Oursler MJ, Osdoby P (1990): Characterization of an osteoclast membrane protein related to superoxide dismutase, calcium regulation and bone metabolism. (Eds. DV Cohen, FH Glorieux and TJ Martin). Elsevier Science Publishers, pp. 214-220.
61. Oursler MJ (1994): Osteoclast synthesis, secretion and activation of latent transforming growth factor beta. J Bone Miner Res 9(4):443-452.
62. Owens JM, Gallagher AC, Chambers TJ (1996): Bone cells required for osteoclastic resorption but not for osteoclastic differentiation. Biochem Biophys Res Commun 222:225-229.
63. Owens JM, Matsuo K, Touko M, Wagner EF, Chambers TJ (1997): Fra-I stimulates osteoclastic differentiation and function in bipotential osteoclast-macrophage precursors. J Bone Miner Res 12:5108 (Abstract).
64. Pacifici R (1996): Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051.
65. Passeri G, Girasole G, Jilka RL, Manolagas SC (1993): Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828.
66. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM, Leary AC, Sibley B, Clark SC, Williams DA, Yang YC (1990): Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87:7512-7516.
67. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989): Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118.
68. Quinn JMW, Sabokbar A, Denne M, de Vernejoul MC, McGee JOD, Athanasou NA (1997): Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tiss Intl 60:63-70.
69. Reddy SV, Takahashi S, Dallas M, Williams RE, Neckers L, Roodman GD (1994): IL-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Miner Res 9:753-757.
70. Riancho JA, Zarrabeitia MT, Gonzalez-Macias J (1993): Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochem Biophys Res Commun 196:678-685.
71. Rodan GA, MartinTJ (1981): Role of osteoblasts in hormonal control of bone resorption: A hypothesis. Calcif Tiss Intl 33:349-351.
72. Roodman GD (1996): Advances in bone biology: The osteoclast. Endocrine Rev 17:308-332.
73. Roux S, Pichaud F, Quinn J, lalande A, Morieux C, Jullienne A, de Vernejoul MC (1997): Effects of prostaglandins on human hematopoietic osteoclast precursors. Endocrinology 138:1476-1482.
74. Sarma U, Flanagan AM (1996): Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 88:2531-2540.
75. Sato T, Abe E, Jin CH, Hong MH, Katagiri T, Kinoshita T, Amizuka N, Ozawa H, Suda T (1993): The biological roles of the third component of complement in osteoclast formation. Endocrinology 133:397-404.
76. Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE (1997): Rescue of osteoclast function by transgenic expression of kinase-deficient src in src-1-mutant mice. Genes Dev 11:2835-2844.
77. Shevde N, Anklesaria P, Greenberger JS, Bleiberg I, Glowacki J (1994): Stromal cell-mediated stimulation of osteoclastogenesis. Proc Soc Exp Biol Med 205:306-315.
78. Shibutani T, Heersche JN (1993): Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts. J Bone Miner Res 8:331-336.
79. Simonet WS, Lacey DL, Dunstan CR, Kelley M et al. (1997): Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 309-319.
80. Soriano P, Montgomery C, Geske R, Bradley A (1991): Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
81. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N (1995): Modulation of osteoclast differentiation by local factors. Bone 17:87S-91S.
82. Suzuki Y, Morita I, Yamane Y, Murota S (1990): Preventive effect of zinc against cadmium-induced bone resorption. Toxicology 62:27-34.
83. Takahashi N, Mundy GR, Roodman GD (1986): Recombinant human interferon-g inhibits formation of human osteoclast-like cells. J Immunol 137:3544-3549.
84. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T (1988): A osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinolgy 122:1373-1382.
85. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T (1988a): Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602.
86. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T (1991): Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology 128:1792-1796.
87. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T (1991a): Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 6(9):977-985.
88. Takahashi N, Udagawa N, Tanaka S, Hurakami H, Owan I, Tamura T, Suda T (1994): Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Develop Biol 163:212-221.
89. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD (1995): Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95(1):167-171.
90. Takahashi S, Reddy SV, Dallas M, Devlin R, Chou JY, Roodman GD (1995a): Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation. Endocrinology 136:1441-1449.
91. Takami M, Woo JT, Takahashi N, Suda T, Nagai K (1997): Ca2+-ATPase inhibitors and Ca2+ ionophore induce osteoclast-like cell formation in the cocultures of mouse bone marrow cells and calvarial cells. Biochem Biophys Res Commun 237:111-115.
92. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T (1993): Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91(1):257-263.
93. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R (1996): C-cbl is downstream of -src in a signalling pathway necessary for bone resorption. Nature 383:528-531.
94. Tani-Ishii N, Tsunoda A, Umemoto T (1997): Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro. J Periodont Res 32:480-486.
95. Tashjian AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L (1985): Alpha and beta transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 82:4535-4538.
96. Teti A, Rizzoli R, Zambonin-Zallone A (1991): A parathyroid hormone binding to cultured avian osteoclasts. Biochem Biophys Res Commun 174:1217-1222.
97. Tondravi MM, McKercher SR, Andersen K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL (1997): Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386:81-84.
98. Tong H, Lin H, Wang H, Sakai D, Minkin C (1995): Osteoclasts respond to parathyroid hormone and express mRNA for its receptor. J Bone Miner Res 10:S322.
99. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T (1989): The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805-1813.
100. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto et al. (1995): Interleukin-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
101. Udagawa N, Chan J, Wada S, Findlay DM, Hamilton JA, Martin TJ (1996): c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro. Bone 18:511-516.
102. Uy HL, Guise TA, De La Mata J, Taylor SD, Story BM, Dallas MR, Boyce BF, Mundy GR, Roodman GD (1995): Effects of parathyroid hormone-related protein and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology 136:3207-3212.
103. Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA (1997): Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Can Res 57:3194-3199.
104. Wada S, Udagawa N, Akatsu T, Nagata N, Martin TJ, Findlay DM (1997): Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology 138:521-529.
105. Wagner EF, Owens J, Chambers TJ, Schreiber M, Matsuo K (1998): Fos proteins in bone cell differentiation and development. Bone 22:35S (abstract).
106. Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka K, Tanaka H, Rodan GA, Rodan SB (1995): Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp Cell Res 219:679-686.
107. Wilson AK, Cerny EA, Smith BD, Wagh A, Bhattacharyya MH (1996): Effect of cadmium on osteoclast formation and activity in vitro. Toxicology & Applied Pharm 140:451-460.
108. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y (1997): TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-80.
109. Woods C, Domenget C, Solari F, Gandrillon O, Lazarides E, Judic P (1995): Antagonistic role of vitamin D3 and retinoic acid on the differentiation of chicken hematopoietic macrophages into osteoclast precursor cells. Endocrinology 136:85-95.
110. Xing L, Franzoso G, Siebenlist U, Boyce BF (1997): Targeted disruption of the p50 and p52 subunits of NF-κB transcription factor leads to failure of osteoclast formation and osteopetrosis. J Bone Miner Res 12:S136 (Abstract).
111. Yamane T, Kunisada T, Yamazaki H, Era T, Nakano T, Hayashi SI (1997): Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90:3516-3523.
112. Yasuda H, Shima N, Nakagawa N, Mochizuki S, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K (1998): Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endrocrinology 139(3):1329-1337.
113. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998a): Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
114. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okumura H, Sudo T, Schultz LD, Nishikawa S (1990): The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature 345:442-444.